Operations Overview
Executive & Operations Dashboard
Upstream reimbursement-readiness across evaluated laboratory orders. All figures are synthetic.
Synthetic demonstration environment. All patients, providers, payers and policies are fictional. Do not enter real patient information. This is not clinical guidance and not evidence of coverage or payment.
What needs attention now?
54
Issues caught before testing
142
Orders Evaluated Today
83
READY
36
ACTION NEEDED
15
REVIEW REQUIRED
54
Issues Before Testing
20
Open Clarifications
11
Human Reviews Pending
10
Live Orders (session)
Order Readiness Ledger
141 evaluated83
36
15
Baseline volumes are synthetic illustrative figures for demonstration only. Live counts reflect just the prototype's own synthetic orders — there is no real order volume.
READY
83
59% of evaluated
ACTION NEEDED
36
26% of evaluated
REVIEW REQUIRED
15
11% of evaluated
UNABLE TO EVALUATE
7
5% of evaluated
Daily Order Trend
- Orders
- READY
Top Unresolved Requirements
BSymptom duration22
DManagement impact14
CClinical indication7
ARespiratory symptom3
Policy / Rule Trigger Frequency
ACriterion A118
BCriterion B96
CCriterion C88
DCriterion D74
ECriterion E128
Clarification Turnaround (hrs)
Estimated Avoided Rework
Illustrative / Synthetic$ —
Requires real-world validation.
Estimated At-Risk Testing
Illustrative / Synthetic$ —
Requires real-world validation.
Future Capability
Laboratory Commercial & Reimbursement Intelligence
Potential future capability to help laboratories evaluate reimbursement and operational requirements when launching or expanding diagnostic tests — payer requirement landscape, documentation burden, test-launch readiness, provider readiness, policy-change impact.
Not implemented — roadmap only